Evidence map›Paper›PMID 26582101›Full record

ArticleNano biomedicine and engineering

Enhancement of the Chemiluminescence Response of Enzymatic Reactions by Plasmonic Surfaces for Biosensing Applications.

Biebele Abel, Babatunde Odukoya, Muzaffer Mohammed, Kadir Aslan

Abstract read
In one paragraph

Article in Nano biomedicine and engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Metal oxide surfaces for enhanced colorimetric response in bioassays.Colloids and surfaces. B, Biointerfaces · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Biebele AbelMorgan State University, Department of Chemistry, 1700 East Cold Spring Lane, Baltimore, MD 21251 USA.
Babatunde OdukoyaMorgan State University, Department of Chemistry, 1700 East Cold Spring Lane, Baltimore, MD 21251 USA.
Muzaffer MohammedMorgan State University, Department of Chemistry, 1700 East Cold Spring Lane, Baltimore, MD 21251 USA.
Kadir AslanMorgan State University, Department of Chemistry, 1700 East Cold Spring Lane, Baltimore, MD 21251 USA.

Funding

Ultra Fast and Sensitive Fluorescence-Based Clinical AssaysK25EB007565 · NIBIB · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI ASLAN, KADIR · 2008 to 2011
$607k
NIBIB NIH HHS K25 EB007565
6 · The paper itself

Abstract

We report the enhancement of chemiluminescence response of horseradish peroxidase (HRP) in bioassays by plasmonic surfaces, which are comprised of (i) silver island films (SIFs) and (ii) metal thin films (silver, gold, copper, and nickel, 1 nm thick) deposited onto glass slides. A model bioassay, based on the interactions of avidin-modified HRP with a monolayer of biotinylated poly(ethylene-glycol)-amine, was employed to evaluate the ability of plasmonic surfaces to enhance chemiluminescence response of HRP. Chemiluminescence response of HRP in model bioassays were increased up to ~3.7-fold as compared to the control samples (i.e. glass slides without plasmonic nanoparticles), where the largest enhancement of the chemiluminescence response was observed on SIFs with high loading. These findings allowed us to demonstrate the use of SIFs (high loading) for the detection of a biologically relevant target protein (glial fibrillary acidic protein or GFAP), where the chemiluminescence response of the standard bioassay for GFAP was enhanced up to ~50% as compared to bioassay on glass slides.

Indexed as

amplification of chemiluminescence responseglial fibrillary acidic proteinhorse radish peroxidasemetal-enhanced chemiluminescencemetal-enhanced fluorescenceSilver island films

Identifiers

PMID26582101
PMCPMC4646423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.